Literature DB >> 2568827

Characteristics of passive immunity against hantavirus infection in rats.

X K Zhang1, I Takashima, N Hashimoto.   

Abstract

The protective effects of passively administered antibodies against hantavirus infection were studied in newborn rats. Death as well as infection were completely prevented from intraperitoneal challenge of strain SR-11 (SR) (2 x 10(3) FFU, 10(2.1) LD50), in newborn rats which received 0.1 ml of anti-SR rat serum (neutralizing antibody titer, 1:640) 4 hr before the virus challenge. In these rats, no virus was detected in the peritoneal macrophages, lung, kidney, and brain. The immune serum infusion before the virus challenge also conferred protection to rats against an intramuscular or subcutaneous challenge of strain SR, but did not protect the rats against intracerebral challenge of the virus. In the rats which received the immune serum after the challenge, infection was not prevented, although some of the animals were protected from the death. Virus titers in the lung, kidney, and brain of the rats were reduced by the transfer of the immune serum even as late as 72 hr after the challenge. Cross-protection in the rats which received the immune serum was strong between strains SR and KI-262 within the same serotype, but very weak between strains SR and Hantaan 76-118 of different serotypes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568827     DOI: 10.1007/BF01311360

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  24 in total

1.  Viruses of hemorrhagic fever with renal syndrome (HFRS) grouped by immunoprecipitation and hemagglutination inhibition.

Authors:  J R Dantas; Y Okuno; O Tanishita; Y Takahashi; M Takahashi; T Kurata; H W Lee; K Yamanishi
Journal:  Intervirology       Date:  1987       Impact factor: 1.763

2.  Partial characterization of Prospect Hill virus isolated from meadow voles in the United States.

Authors:  P W Lee; H L Amyx; R Yanagihara; D C Gajdusek; D Goldgaber; C J Gibbs
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

3.  Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system.

Authors:  T Kitamura; C Morita; T Komatsu; K Sugiyama; J Arikawa; S Shiga; H Takeda; Y Akao; K Imaizumi; A Oya; N Hashimoto; S Urasawa
Journal:  Jpn J Med Sci Biol       Date:  1983-02

4.  Permeability of the blood-cerebrospinal fluid barrier to plasma proteins during foetal and perinatal life.

Authors:  M Adinolfi; S E Beck; S A Haddad; M J Seller
Journal:  Nature       Date:  1976-01-15       Impact factor: 49.962

5.  Four serotypes of haemorrhagic fever with renal syndrome viruses identified by polyclonal and monoclonal antibodies.

Authors:  K Sugiyama; S Morikawa; Y Matsuura; E A Tkachenko; C Morita; T Komatsu; Y Akao; T Kitamura
Journal:  J Gen Virol       Date:  1987-04       Impact factor: 3.891

6.  Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus).

Authors:  R Yanagihara; H L Amyx; D C Gajdusek
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

7.  Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius.

Authors:  H W Lee; P W Lee; L J Baek; C K Song; I W Seong
Journal:  Am J Trop Med Hyg       Date:  1981-09       Impact factor: 2.345

8.  Laboratory rat associated outbreak of haemorrhagic fever with renal syndrome due to Hantaan-like virus in Belgium.

Authors:  J Desmyter; J W LeDuc; K M Johnson; F Brasseur; C Deckers; C van Ypersele de Strihou
Journal:  Lancet       Date:  1983 Dec 24-31       Impact factor: 79.321

9.  Etiologic studies of epidemic hemorrhagic fever (hemorrhagic fever with renal syndrome).

Authors:  G Song; C S Hang; X Z Qui; D S Ni; H X Liao; G Z Gao; Y L Du; J K Xu; Y S Wu; J N Zhao; B X Kong; Z S Wang; Z Q Zhang; H K Shen; N Zhou
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

10.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

View more
  17 in total

Review 1.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

Review 2.  Treatment of hantavirus pulmonary syndrome.

Authors:  Colleen B Jonsson; Jay Hooper; Gregory Mertz
Journal:  Antiviral Res       Date:  2007-11-21       Impact factor: 5.970

3.  Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.

Authors:  C S Schmaljohn; Y K Chu; A L Schmaljohn; J M Dalrymple
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

Authors:  J W Hooper; D M Custer; E Thompson; C S Schmaljohn
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.

Authors:  Andrea Bertolotti-Ciarlet; Jonathan Smith; Karin Strecker; Jason Paragas; Louis A Altamura; Jeanne M McFalls; Natalia Frias-Stäheli; Adolfo García-Sastre; Connie S Schmaljohn; Robert W Doms
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Natural host relationships of hantaviruses native to western Venezuela.

Authors:  Mary L Milazzo; Gloria Duno; Antonio Utrera; Martin H Richter; Freddy Duno; Nuris de Manzione; Charles F Fulhorst
Journal:  Vector Borne Zoonotic Dis       Date:  2010-08       Impact factor: 2.133

7.  Hantavirus-specific CD8(+)-T-cell responses in newborn mice persistently infected with Hantaan virus.

Authors:  Koichi Araki; Kumiko Yoshimatsu; Byoung-Hee Lee; Hiroaki Kariwa; Ikuo Takashima; Jiro Arikawa
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.

Authors:  Rebecca L Brocato; Christopher D Hammerbeck; Todd M Bell; Jay B Wells; Laurie A Queen; Jay W Hooper
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.

Authors:  D M Custer; E Thompson; C S Schmaljohn; T G Ksiazek; J W Hooper
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).

Authors:  Jay W Hooper; Matthew Josleyn; John Ballantyne; Rebecca Brocato
Journal:  Vaccine       Date:  2013-07-24       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.